For #RareDiseaseDay 2022, SynGAP Research Fund (SRF) announces a partnership with Probably Genetic to find more patients -- the campaign is called #CouldItBeSYNGAP1. The partners have developed a ...

My son was diagnosed with SynGAP, a rare genetic disorder. It causes seizures, sleep disorders, intellectual impairment, aggression, and other risk factors. My wife and I have raised over four million ...

Syngap is probably not something you know about off the top of your head. According to their website SYNGAP1-related non-syndromic intellectual disability is a rare genetic disorder caused by a ...

TURKU, Finland – October 27, 2023 – The SynGAP Research Fund 501(c)(3) announced a $100,000 grant to researchers Pekka Postila and Olli Pentikäinen from the Institute of Biomedicine and InFLAMES ...

Hattie Foster looks up to the sky. She’s 6 years old. The sun is shining, and she’s buzzing with energy. “Where’s the moon?” she asks whoever is listening. Her older brother, 9-year-old Charlie, ...

The SynGAP Research Fund (SRF) awarded a $128,000 grant to Joseph Anderson, PhD, associate director of the University of California-Davis Gene Therapy Center and associate professor at UC-Davis. Based ...

NEW YORK, June 8, 2021 /PRNewswire/ — The SynGAP Research Fund (SRF) announces a new research grant award to the Coba Laboratory in the Zilkha Neurogenetic Institute at the University of Southern ...

SynGAP Research Fund (SRF), a 501(c)(3) public charity whose mission is to improve the quality of life for SYNGAP1 patients through the research and development of treatments, therapies and support ...

CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of ...

Syngap Research Fund is a 501(c)(3) public charity incorporated in 2018. The mission is to improve the quality of life of SYNGAP1 patients through the research and development of treatments, therapies ...